Bullboard - Stock Discussion Forum IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a... see more

Add To Watchlist

TSXV:IBT - Post Discussion

IBEX Technologies Inc > Could Afford a dividend

View:

Post by nozzpack on Dec 20, 2021 1:16pm

Could Afford a dividend

1 cent semiannually would costs just $500,000 per year.
They have the cash and cash flow, with the caveat that such a dividend would be reviewed annually..

Comment

Comment by guarantor1 on Dec 21, 2021 5:41am

Paul Baehr has been asked about a dividend, in the past...and he was not a big fan of the concept. Quarterly financials can be very erratic, and he wants a cushion. And I suspect initial DAO Marketing, a coupke years down the road, won't be cheap. That being said ...it's pretty well acknowledged that a divident would give IBT a lot more exposure, and help the stockprice. And they now ...more

Comment

Comment by nozzpack on Dec 21, 2021 9:12am

Thank you. I prefer to use cash for growth but realize that a dividend would do wonders for the share price. However, if this niche is constrained in terms of acquisition opps, and we have significant organic growth within 2 years with the new DAO product, then the major shareholder might tip the hand towards a modest dividend, post year end , reflective of previous financial year profitability.

Comment

IBEX Technologies Inc